Literature DB >> 15947997

Two missense mutations of EGR2 R359W and GJB1 V136A in a Charcot-Marie-Tooth disease family.

K W Chung1, I N Sunwoo, S M Kim, K D Park, W-K Kim, T S Kim, H Koo, M Cho, J Lee, B O Choi.   

Abstract

During mutational analysis of Charcot-Marie-Tooth (CMT) causative genes, we identified a CMT family with two missense mutations in different genes. A R359W mutation in EGR2 was shared by the affected daughter (proband) and her father. In addition, she had a V136A mutation in GJB1, which was determined to be a de novo mutation. The daughter with two different gene mutations showed more severe clinical, electrophysiological and histopathological phenotypes than her father who had only the EGR2 mutation. We suggest that these phenotypic differences between the proband and her father may have been caused by an altered effect of the genetic modifier in EGR2, or by the additive effect of the EGR2 and GJB1 mutations.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15947997     DOI: 10.1007/s10048-005-0217-4

Source DB:  PubMed          Journal:  Neurogenetics        ISSN: 1364-6745            Impact factor:   2.660


  16 in total

Review 1.  Disease mechanisms in inherited neuropathies.

Authors:  Ueli Suter; Steven S Scherer
Journal:  Nat Rev Neurosci       Date:  2003-09       Impact factor: 34.870

2.  Four novel mutations of the connexin 32 gene in four Japanese families with Charcot-Marie-Tooth disease type 1.

Authors:  T Ikegami; C Lin; M Kato; A Itoh; I Nonaka; M Kurimura; H Hirayabashi; Y Shinohara; A Mochizuki; K Hayasaka
Journal:  Am J Med Genet       Date:  1998-12-04

Review 3.  Demyelinating and axonal features of Charcot-Marie-Tooth disease with mutations of myelin-related proteins (PMP22, MPZ and Cx32): a clinicopathological study of 205 Japanese patients.

Authors:  Naoki Hattori; Masahiko Yamamoto; Tsuyoshi Yoshihara; Haruki Koike; Masanori Nakagawa; Hiroo Yoshikawa; Akio Ohnishi; Kiyoshi Hayasaka; Osamu Onodera; Masayuki Baba; Hitoshi Yasuda; Toyokazu Saito; Kenji Nakashima; Jun-ichi Kira; Ryuji Kaji; Nobuyuki Oka; Gen Sobue
Journal:  Brain       Date:  2003-01       Impact factor: 13.501

4.  Screening for mutations in the peripheral myelin genes PMP22, MPZ and Cx32 (GJB1) in Russian Charcot-Marie-Tooth neuropathy patients.

Authors:  I V Mersiyanova; S M Ismailov; A V Polyakov; E L Dadali; V P Fedotov; E Nelis; A Löfgren; V Timmerman; C van Broeckhoven; O V Evgrafov
Journal:  Hum Mutat       Date:  2000       Impact factor: 4.878

5.  Functional consequences of mutations in the early growth response 2 gene (EGR2) correlate with severity of human myelinopathies.

Authors:  L E Warner; J Svaren; J Milbrandt; J R Lupski
Journal:  Hum Mol Genet       Date:  1999-07       Impact factor: 6.150

6.  Novel missense mutation in the early growth response 2 gene associated with Dejerine-Sottas syndrome phenotype.

Authors:  V Timmerman; P De Jonghe; C Ceuterick; E De Vriendt; A Löfgren; E Nelis; L E Warner; J R Lupski; J J Martin; C Van Broeckhoven
Journal:  Neurology       Date:  1999-06-10       Impact factor: 9.910

Review 7.  Gap junctions: structure and function (Review).

Authors:  W Howard Evans; Patricia E M Martin
Journal:  Mol Membr Biol       Date:  2002 Apr-Jun       Impact factor: 2.857

8.  Mutational analysis of PMP22, MPZ, GJB1, EGR2 and NEFL in Korean Charcot-Marie-Tooth neuropathy patients.

Authors:  Byung-Ok Choi; Mi Sun Lee; Sang Hee Shin; Jung Hee Hwang; Kyoung-Gyu Choi; Won-Ki Kim; Il Nam Sunwoo; Nam Keun Kim; Ki Wha Chung
Journal:  Hum Mutat       Date:  2004-08       Impact factor: 4.878

9.  Spectrum of mutations in Finnish patients with Charcot-Marie-Tooth disease and related neuropathies.

Authors:  K Silander; P Meretoja; V Juvonen; J Ignatius; H Pihko; A Saarinen; T Wallden; E Herrgård; P Aula; M L Savontaus
Journal:  Hum Mutat       Date:  1998       Impact factor: 4.878

10.  Krox-20 controls myelination in the peripheral nervous system.

Authors:  P Topilko; S Schneider-Maunoury; G Levi; A Baron-Van Evercooren; A B Chennoufi; T Seitanidou; C Babinet; P Charnay
Journal:  Nature       Date:  1994-10-27       Impact factor: 49.962

View more
  13 in total

1.  Compound heterozygosity for loss-of-function lysyl-tRNA synthetase mutations in a patient with peripheral neuropathy.

Authors:  Heather M McLaughlin; Reiko Sakaguchi; Cuiping Liu; Takao Igarashi; Davut Pehlivan; Kristine Chu; Ram Iyer; Pedro Cruz; Praveen F Cherukuri; Nancy F Hansen; James C Mullikin; Leslie G Biesecker; Thomas E Wilson; Victor Ionasescu; Garth Nicholson; Charles Searby; Kevin Talbot; Jeffrey M Vance; Stephan Züchner; Kinga Szigeti; James R Lupski; Ya-Ming Hou; Eric D Green; Anthony Antonellis
Journal:  Am J Hum Genet       Date:  2010-10-08       Impact factor: 11.025

2.  Clan genomics and the complex architecture of human disease.

Authors:  James R Lupski; John W Belmont; Eric Boerwinkle; Richard A Gibbs
Journal:  Cell       Date:  2011-09-30       Impact factor: 41.582

3.  Comprehensive Molecular Diagnosis of a Large Chinese Leber Congenital Amaurosis Cohort.

Authors:  Hui Wang; Xia Wang; Xuan Zou; Shan Xu; Hui Li; Zachry Tore Soens; Keqing Wang; Yumei Li; Fangtian Dong; Rui Chen; Ruifang Sui
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-06       Impact factor: 4.799

4.  Myotonic dystrophy type I combined with X-linked dominant Charcot-Marie-Tooth neuropathy.

Authors:  Hyun Sook Kim; Ki Wha Chung; Sung Hee Kang; Sung Kyung Choi; Sun Young Cho; Heasoo Koo; Sang-Beom Kim; Byung-Ok Choi
Journal:  Neurogenetics       Date:  2010-05-05       Impact factor: 2.660

Review 5.  Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease.

Authors:  David N Cooper; Michael Krawczak; Constantin Polychronakos; Chris Tyler-Smith; Hildegard Kehrer-Sawatzki
Journal:  Hum Genet       Date:  2013-07-03       Impact factor: 4.132

6.  Whole-genome sequencing in a patient with Charcot-Marie-Tooth neuropathy.

Authors:  James R Lupski; Jeffrey G Reid; Claudia Gonzaga-Jauregui; David Rio Deiros; David C Y Chen; Lynne Nazareth; Matthew Bainbridge; Huyen Dinh; Chyn Jing; David A Wheeler; Amy L McGuire; Feng Zhang; Pawel Stankiewicz; John J Halperin; Chengyong Yang; Curtis Gehman; Danwei Guo; Rola K Irikat; Warren Tom; Nick J Fantin; Donna M Muzny; Richard A Gibbs
Journal:  N Engl J Med       Date:  2010-03-10       Impact factor: 91.245

7.  Charcot-marie-tooth disease: seventeen causative genes.

Authors:  Jung-Hwa Lee; Byung-Ok Choi
Journal:  J Clin Neurol       Date:  2006-06-20       Impact factor: 3.077

8.  Compound Charcot-Marie-Tooth disease may determine unusual and milder phenotypes.

Authors:  Silmara P Gouvea; Vinícius H S Borghetti; Keity C Bueno; Adriana B Genari; Charles M Lourenço; Claudia Sobreira; Amilton A Barreira; Wilson Marques
Journal:  Neurogenetics       Date:  2009-08-25       Impact factor: 2.660

Review 9.  Genetic modifiers and non-Mendelian aspects of CMT.

Authors:  Dana M Bis-Brewer; Sarah Fazal; Stephan Züchner
Journal:  Brain Res       Date:  2019-09-13       Impact factor: 3.252

Review 10.  New evidence for secondary axonal degeneration in demyelinating neuropathies.

Authors:  Kathryn R Moss; Taylor S Bopp; Anna E Johnson; Ahmet Höke
Journal:  Neurosci Lett       Date:  2020-12-24       Impact factor: 3.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.